Dog Diabetes Mellitus: Comprehensive Management Guide

Practical, evidence-based guide to canine diabetes: causes, diagnosis, insulin therapy (Vetsulin, NPH), monitoring, diet, hypoglycaemia, and living with a diabetic dog.

Quick Overview

• What it is: Diabetes mellitus in dogs is a chronic disorder in which the body cannot regulate blood glucose because of absent or insufficient insulin secretion and/or significant insulin resistance. Most dogs develop insulin-dependent disease resembling Type 1 diabetes in people (beta-cell loss requiring lifelong insulin).
• Who’s at risk: Middle-aged to older dogs, intact or previously intact females, certain breeds (see below), obese dogs, and dogs with concurrent endocrine disease (e.g., hyperadrenocorticism). Pancreatitis can trigger or complicate diabetes.
• Prognosis: With consistent insulin therapy, diet, monitoring and veterinary support most dogs can live months to years with good quality of life. True remission is uncommon in dogs (much less common than in cats).

Insulin is the hormone that helps cells take up glucose from the bloodstream. In most diabetic dogs, immune-mediated destruction or other damage to pancreatic beta cells leads to inadequate insulin production (an insulin-deficient state). Without enough insulin, blood glucose rises, tissues starve for energy, and the body catabolizes fat and muscle. Severe uncontrolled diabetes can progress to diabetic ketoacidosis (DKA), a life‑threatening emergency.

Breed-specific risk factors and prevalence

• Higher-risk breeds: Schnauzers (miniature), Dachshunds, Poodles (miniature), Bichon Frise, Samoyeds, Keeshonds, Labrador Retrievers, and others have been overrepresented in studies.
• Sex/age: Middle-aged to older dogs; female dogs historically over-represented in some populations (possible hormonal influences).
• Prevalence: Canine diabetes is less common than in people; estimates vary by region. The pattern in dogs is generally insulin-dependent (Type 1–like) rather than Type 2.

Common signs

• Increased thirst (polydipsia) and urination (polyuria)
• Increased appetite (polyphagia) with possible weight loss
• Lethargy or decreased activity
• Recurrent urinary tract infections
• Cataracts (common complication) leading to visual changes
• Vomiting, dehydration, rapid breathing and collapse if DKA develops

• Early diabetes: polyuria/polydipsia, polyphagia, weight loss
• Insulin-requiring diabetes: signs persist until insulin therapy is started
• Complicated diabetes: with infections, uncontrolled hyperglycaemia or DKA

• History and physical exam
• Serum biochemistry (elevated blood glucose; evaluate kidney and liver values)
• Urinalysis (glucosuria; check for ketones and infection)

• Persistent fasting hyperglycaemia on blood testing plus clinical signs and glucosuria confirm diabetes.
• Blood glucose alone can be affected by stress hyperglycaemia; repeat testing or home glucometer monitoring helps.

• Fructosamine: reflects average blood glucose over previous 2–3 weeks; useful to assess control and occasional discordance between clinic readings and home monitoring.
• CBC and serum chemistry: assess for concurrent disease (infections, pancreatitis, liver/kidney disease).
• Pancreatic lipase assay (PLI) or cPL to detect pancreatitis which commonly coexists.
• Urine culture if recurrent infections.

• Abdominal ultrasound: evaluate pancreas, liver, adrenal glands (if hyperadrenocorticism suspected), and urinary tract.

• Consider referral to a veterinary internal medicine specialist if: initial control is poor despite reasonable adjustments, DKA occurs, there are significant comorbidities (e.g., uncontrolled Cushing’s, severe pancreatitis), or for complex insulin regimen adjustments.

Medical (mainstay)

• Dogs almost always require exogenous insulin. Aim is to reduce hyperglycaemia and avoid hypoglycaemia, restore normal energy balance, and prevent complications.
• Most dogs are treated with twice-daily (q12h) insulin given consistently with meals.

• Vetsulin (porcine lente insulin): labeled and commonly used for dogs. Often given twice daily. Vetsulin is a lente insulin with intermediate duration.
• NPH (Neutral Protamine Hagedorn, e.g., Humulin N): a human intermediate-acting insulin frequently used successfully in dogs on a twice-daily schedule.
• Long-acting insulins (glargine, detemir) are used less commonly in dogs than in cats but may be considered in special cases; use only under specialist guidance.

• Common starting dose: 0.25–0.5 units/kg SC every 12 hours. Many clinicians start at the lower end (0.25 U/kg) in debilitated or small dogs to reduce hypoglycaemia risk and adjust based on glucose curves.
• Dosing must be individualized. Dose changes should be based on clinical signs and glucose monitoring (see below).

• Give insulin at the same times each day relative to feeding. For most preparations give insulin immediately after your dog has eaten to reduce hypoglycaemia risk.
• Store insulin in the refrigerator (do not freeze). Gently roll the Vetsulin vial between hands to resuspend; do not shake vigorously.

• There is no routine surgical cure for typical canine diabetes. Treat underlying causes (e.g., resection of an insulin-secreting tumor — insulinoma — but that causes hypoglycaemia rather than diabetes).
• Spaying entire females with diestrus-related insulin resistance (progesterone-mediated) can correct hormone-driven insulin resistance in some cases; consult your veterinarian.

• Diet: see next section. No oral hypoglycaemic drugs are consistently effective for insulin-deficient dogs.
• Address concurrent disease (e.g., treat hyperadrenocorticism) to improve insulin sensitivity.

Diet

• Objective: provide consistent carbohydrate load and caloric content to match insulin dosing.
• Many vets recommend a high-fiber, moderate- to high-protein, low simple-carbohydrate diet for diabetic dogs to slow glucose absorption and stabilize post-prandial glucose. Veterinary therapeutic diets marketed for diabetic dogs (Hill’s, Royal Canin, Purina) are options.
• If your dog has pancreatitis or is at risk, choose a low-fat prescription diet.
• Feed the same type and amount of food at the same times daily. Give the meal immediately before or at the time you administer insulin to minimize hypoglycaemia.

• Keep exercise routine consistent day-to-day. Sudden increases in activity can increase glucose uptake and predispose to hypoglycaemia; sudden decreases may increase hyperglycaemia.

Home monitoring

• Home blood glucose monitoring using a veterinary-validated glucometer (AlphaTRAK is one commonly used) is extremely helpful. Owners can perform spot checks or full home glucose curves.
• Record daily insulin dose, meal size, appetite, water intake, urination, and activity.

• After initiation or dose change: glucose curve (every 2 hours for 8–12+ hours) within 5–10 days to determine nadir and duration.
• Once stable: recheck every 3 months (or more often early on). Measure weight, physical exam, serum biochemistry, urine analysis, and fructosamine as needed.

• A glucose curve measures blood glucose every ~2 hours after insulin to find the nadir (lowest glucose). Goals in dogs (general guidance):

• Adjust insulin dose by small increments (typically 10–20% of total dose) based on nadir and clinical signs.

• Fructosamine reflects average control over 2–3 weeks and helps assess overall stability when day-to-day glucose fluctuation or stress in clinic confounds single measurements.

• Hyperadrenocorticism (Cushing’s disease): causes insulin resistance and higher insulin requirements. Treating Cushing’s (e.g., trilostane) can help glycaemic control.
• Pancreatitis: can impair insulin production and lead to poor control; often requires dietary change (low-fat) and may precipitate DKA.
• Urinary tract infections and other infections: increase insulin requirements until the infection resolves.
• Obesity, hypothyroidism and certain medications (e.g., glucocorticoids, progestins) affect glucose homeostasis.

Recognize early signs

• Weakness, trembling, ataxia, pacing, wobbliness, collapse, seizures, excessive salivation.

• Rub a glucose source (corn syrup, honey, or Karo syrup) on the gums and between the cheek and gum; follow with small amounts of food when the dog can swallow safely.
• Continue to contact your veterinarian immediately for next steps and re-evaluation.

• This is an emergency. Do NOT attempt oral administration. Transport to an emergency clinic immediately.
• At the clinic, IV dextrose is given (typical emergency bolus ~0.25–0.5 g/kg dextrose IV; for example 0.5–1 mL/kg of 50% dextrose diluted appropriately). Treatment must be performed by a veterinarian.

• Give insulin only after food is consumed, confirm dose, avoid extra exercise after insulin, and keep a consistent feeding/exercise schedule.

• Many dogs with diabetes live comfortable, active lives with appropriate management. Common complications include cataracts, urinary infections, pancreatitis, and hypoglycaemia episodes.
• Median survival times reported vary; many dogs do well for 1–3 years or longer with consistent care. True remission (no longer requiring insulin) is uncommon in dogs (<10–20% in most reports) and should not be expected.

• Create a daily routine: same feeding times, same insulin schedule, same exercise.
• Keep an insulin log: dose, time, meal size, BG readings, clinical signs.
• Use a veterinary glucometer validated for dogs; learn correct blood collection technique.
• Rotate injection sites (scruff, lateral thorax) and inspect skin for lumps or irritation.
• Carry a “diabetic emergency kit” with glucose source (syrup/honey), a copy of insulin dose and vet contact, and your vet’s emergency number.
• Microchip and ID tag that notes “Diabetic — insulin” and emergency contact.
• Keep insulin refrigerated; check expiration date and discard if frozen or contaminated.
• Travel preparations: pack insulin, syringes, documents, and days’ worth of food; maintain routine.

• Persistent vomiting, diarrhea, or not eating for >24 hours
• Marked lethargy, collapse or seizures
• Rapid breathing, dehydration, or loss of consciousness
• Blood glucose consistently above ~300–400 mg/dL with clinical signs or ketonuria
• Any hypoglycaemic episode that is severe or prolonged

• Insulin therapy successfully controls clinical signs in most dogs. Hospitalization is required for DKA or severe dehydration.
• Long-term control depends on owner compliance, ability to monitor, and management of concurrent disease. Dogs with well-managed diabetes can have good quality of life.

• Diabetes in dogs is most often insulin-dependent and requires long-term insulin, consistent diet and routine, and regular monitoring.
• Vetsulin and NPH are frequently used intermediate-acting insulins in dogs; typical starting dose is 0.25–0.5 U/kg SC q12h and adjustments are guided by glucose curves and clinical signs.
• Hypoglycaemia is a real risk — know how to respond and when to seek emergency care.
• Treat concurrent disease (Cushing’s, pancreatitis, infections) to improve control.

References and further reading

• Merck Veterinary Manual: Diabetes Mellitus in Dogs and Cats. https://www.merckvetmanual.com/endocrine-system/diabetes-mellitus/diabetes-mellitus-in-dogs-and-cats
• American College of Veterinary Internal Medicine (ACVIM) consensus statements and clinical resources on diabetes management.
• Peer-reviewed veterinary endocrinology reviews and treatment guidelines (see your veterinarian for relevant literature and individualized plans).

Frequently Asked Questions